These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1904653

  • 1. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
    Sane DC, Stump DC, Topol EJ, Sigmon KN, Kereiakes DJ, George BS, Mantell SJ, Macy E, Collen D, Califf RM.
    Thromb Haemost; 1991 Mar 04; 65(3):275-9. PubMed ID: 1904653
    [Abstract] [Full Text] [Related]

  • 2. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ.
    Thromb Haemost; 1999 Jul 04; 82(1):104-8. PubMed ID: 10456462
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S, Yamada R, Ishii A, Ashikawa K, Kawamitsu H, Fujita K.
    J Cardiol; 1996 Apr 04; 27(4):171-8. PubMed ID: 8642503
    [Abstract] [Full Text] [Related]

  • 4. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K, Beckmann R, Rauscha F, Probst P, Kaindl F, Binder BR.
    Z Kardiol; 1993 Apr 04; 82 Suppl 2():195-200. PubMed ID: 8328203
    [Abstract] [Full Text] [Related]

  • 5. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y, Ogawa H, Oshima S, Arai H, Takazoe K, Shimomura H, Hirai N, Suefuji H, Soejima H, Nishiyama K, Misumi K, Yasue H.
    Coron Artery Dis; 1998 Apr 04; 9(10):691-6. PubMed ID: 9894621
    [Abstract] [Full Text] [Related]

  • 6. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR.
    Thromb Haemost; 1988 Dec 22; 60(3):372-6. PubMed ID: 3149044
    [Abstract] [Full Text] [Related]

  • 7. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis.
    Huber K, Jörg M, Probst P, Schuster E, Lang I, Kaindl F, Binder BR.
    Thromb Haemost; 1992 Feb 03; 67(2):209-13. PubMed ID: 1621240
    [Abstract] [Full Text] [Related]

  • 8. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
    Chen HZ, Jia HY, Song HY, Wang JY.
    Chin Med J (Engl); 1990 Jul 03; 103(7):541-5. PubMed ID: 2119970
    [Abstract] [Full Text] [Related]

  • 9. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M, Nakabayashi T, Iuchi K, Ishikawa T, Kaseno K, Yoshida T, Asakura H, Matsuda T.
    Blood Coagul Fibrinolysis; 1993 Oct 03; 4(5):801-4. PubMed ID: 7507363
    [Abstract] [Full Text] [Related]

  • 10. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R.
    Klin Wochenschr; 1988 Oct 03; 66 Suppl 12():77-85. PubMed ID: 3126348
    [Abstract] [Full Text] [Related]

  • 11. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
    Hirashima O, Ogawa H, Oshima S, Sakamoto T, Honda Y, Sakata S, Masuda T, Miyao Y, Yasue H.
    Am Heart J; 1995 Nov 03; 130(5):933-9. PubMed ID: 7484753
    [Abstract] [Full Text] [Related]

  • 12. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
    Barbash GI, Hod H, Roth A, Miller HI, Rath S, Zahav YH, Modan M, Zivelin A, Laniado S, Seligsohn U.
    Am J Cardiol; 1989 Dec 01; 64(19):1231-5. PubMed ID: 2511742
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase.
    Rapold HJ, Grimaudo V, Declerck PJ, Kruithof EK, Bachmann F.
    Blood; 1991 Sep 15; 78(6):1490-5. PubMed ID: 1832058
    [Abstract] [Full Text] [Related]

  • 14. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
    Sakamoto T, Yasue H, Ogawa H, Misumi I, Masuda T.
    Am J Cardiol; 1992 Aug 01; 70(3):271-6. PubMed ID: 1632387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
    Bai XJ, Chen CX, He YL.
    Zhonghua Nei Ke Za Zhi; 1991 Apr 01; 30(4):205-7, 253. PubMed ID: 1908371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.